MET and central nervous system cancer: A novel MET fusion was identified in an IDH-mutant recurrent glioma (MT 60-2) in the G-CIMP-demethylated (C.3) group with RNA-seq and was confirmed with direct sequencing following PCR amplification of the cDNA (Fig. 6a, Supplementary Fig. S7).